lung
among
vulner
microbi
assault
organ
bodi
contemporari
vantag
lower
respiratori
tract
infect
greatest
caus
infectionrel
mortal
unit
state
rank
seventh
among
caus
death
unit
state
global
histor
perspect
scope
scale
lower
respiratori
tract
infect
greater
infecti
syndrom
viral
pneumonia
proven
lethal
dramat
human
diseas
influenza
pandem
perhap
devast
infecti
diseas
pandem
record
histori
result
estim
million
death
worldwid
includ
death
us
global
outbreak
sever
acut
respiratori
syndrom
sar
although
consider
smaller
scale
result
case
death
dramat
contemporari
exampl
abil
viral
pneumonia
rapidli
dissemin
caus
sever
diseas
human
popul
although
virus
commonli
identifi
caus
pneumonia
infant
young
children
rel
infrequ
recogn
agent
communityacquir
pneumonia
adult
sever
larg
seri
investig
microbiolog
caus
communityacquir
pneumonia
viral
etiolog
identifi
case
tabl
howev
like
viral
pneumonia
underrecogn
underdiagnos
variou
reason
although
agent
may
caus
distinct
cytopatholog
inclus
eg
adenovirus
herpesvirus
paramyxovirus
mani
import
pathogen
eg
influenza
virus
none
agent
resolv
specif
tissu
routin
histolog
stain
virus
requir
live
cell
cultiv
gener
difficult
bacteria
isol
clinic
sampl
viral
pneumonia
pathogen
appear
initi
cascad
destruct
host
respons
continu
progress
even
absenc
specif
infecti
agent
patient
etiolog
agent
may
absent
host
tissu
time
thirti
sixti
percent
communityacquir
pneumonia
etiolog
undetermin
entir
possibl
virus
directli
caus
episod
pneumonia
current
appreci
viral
infect
lower
respiratori
tract
often
preced
bacteri
pneumonia
virus
may
indirectli
exert
consider
influenc
cumul
morbid
mortal
infecti
pneumonia
mechan
virus
may
facilit
bacteri
invas
respiratori
tract
complex
vari
certain
virus
caus
death
ciliat
respiratori
epithelium
therebi
disrupt
normal
ciliari
activ
virus
may
also
inhibit
phagocyt
bactericid
activ
neutrophil
lymphocyt
alveolar
macrophag
predispos
host
secondari
infect
certain
gramposit
gramneg
bacteria
adher
colon
virusinfect
epithelium
readili
noninfect
cell
variou
hypothet
mechan
includ
alter
induct
receptor
hostcel
surfac
chang
extracellular
final
viral
infect
lung
may
exacerb
noninfecti
pulmonari
condit
eg
asthma
chronic
obstruct
pulmonari
diseas
indirectli
contribut
aggreg
morbid
mortal
associ
condit
although
influenza
virus
remain
frequent
identifi
caus
viral
pneumonia
adult
tabl
divers
agent
identifi
caus
viral
pneumonia
expand
consider
sever
newli
recogn
viral
pneumonia
identifi
sinc
among
fear
lethal
emerg
infect
includ
caus
hantavirus
nipah
viru
sar
corona
viru
co
v
certain
caus
rubella
rhinoviru
mix
viral
infect
sourc
adapt
greenberg
viral
pneumonia
particularli
occur
vulner
patient
cohort
diminish
interv
exampl
us
incid
varicella
pneumonia
drop
two
third
sinc
univers
childhood
vaccin
varicella
implement
advanc
clinic
manag
transplant
recipi
reduc
incid
cytomegaloviru
cmv
pneumonia
also
occur
last
decad
develop
use
power
molecular
techniqu
unveil
ident
histor
pathogen
eg
hini
spanish
influenza
viru
facilit
rapid
character
emerg
agent
eg
sarsco
v
note
diseas
manifest
sever
agent
eg
human
parainfluenza
viru
hpiv
respiratori
syncyti
viru
rsv
influenza
often
confin
upper
airway
invari
aorb
rsv
hpiv
adeno
cmv
varicella
abli
associ
pneumonia
pathogen
eg
influenza
virus
rsv
hantavirus
hpiv
virus
respiratori
diseas
primari
manifest
agent
measl
nipah
viru
herpesvirus
typic
lung
involv
part
multisystem
syndrom
diagnosi
viral
pneumonia
suspect
patient
histori
clinic
manifest
also
support
histopatholog
gener
pattern
histopatholog
lesion
may
suggest
specif
diagnosi
mani
virus
identifi
lung
examin
tissu
respons
cytopath
chang
virus
caus
recogniz
tissu
reaction
pattern
includ
necrot
tracheobronch
bronchiol
interstiti
pneumonia
summari
key
diagnost
histopatholog
ultrastructur
featur
common
viral
pathogen
caus
major
pulmonari
infect
provid
tabl
ye
cytoplasm
illdefin
ye
nuclear
cytoplasm
pulmonari
tissu
reaction
necrot
bronchiol
smudg
cell
dad
sever
edema
earli
dad
interstiti
pneumonia
dad
occasion
multinucl
interstiti
pneumonia
dad
cytomegali
dad
necrosi
rare
multinucl
dad
necrosi
rare
multinucl
dad
necrot
bronchiol
interstiti
pneumonia
multi
nucleat
dad
dad
interstiti
pneumonia
occasion
multinucl
necrot
bronchiol
interstiti
pneumonia
occasion
multinucl
recent
recogn
human
patholog
well
describ
interstiti
pneumonia
multinucl
dad
certain
virus
caus
cytopath
chang
suffici
distinct
enabl
pathologist
recogn
specif
diagnosi
routin
histolog
examin
lung
specimen
avail
special
figur
neg
stain
electron
microscop
imag
differ
virus
caus
pulmonari
infect
adenoviru
adenovirus
proteinshel
icosahedralshap
nonenvelop
virus
measur
approxim
diamet
two
virus
stain
penetr
reveal
dnacontain
nucleoprotein
b
sin
nombr
viru
sin
nombr
viru
caus
agent
hantaviru
pulmonari
syndrom
belong
genu
hantaviru
famili
bunyavirida
envelop
hantavirus
checkerboard
appear
particl
measur
diamet
c
herp
simplex
viru
stain
penetr
envelop
sever
herpesviru
particl
delin
icosahedralshap
nucleocapsid
measur
diamet
cytomegaloviru
anoth
herpesviru
one
viru
particl
left
intact
two
nearbi
particl
stainpenetr
show
viral
nucleocapsid
nucleocapsid
upper
right
particl
show
central
core
harbor
dna
viru
e
influenza
viru
influenzavirus
belong
famili
orthomyxovirida
viral
particl
pleomorph
sr
zaki
cd
paddock
diagnost
techniqu
immunohistochemistri
ihc
insitu
hybrid
ish
mani
virus
detect
formalinfix
paraffinembed
tissu
sampl
even
specif
viral
inclus
found
histolog
examin
tissu
section
among
techniqu
ihc
util
specif
antibodi
routin
perform
formalinfix
tissu
enhanc
pathologist
accuraci
identifi
organ
tissu
specimen
addit
histolog
pattern
recognit
ihc
ish
tissu
sever
diagnost
test
avail
aid
pathologist
cell
cultur
techniqu
serolog
polymeras
chain
reaction
pcr
electron
microscopi
em
play
vital
role
diagnosi
infect
histolog
techniqu
excel
mean
demonstr
organ
tissu
cultur
isol
remain
essenti
definit
identif
viru
viral
pneumonia
suspect
sampl
lung
tissu
evalu
cell
cultur
advantag
nonbias
method
screen
purpos
reli
avail
specif
antibodi
probe
electron
microscopi
offer
util
broad
scope
diagnost
tool
especi
critic
outbreak
unknown
etiolog
play
critic
role
hendra
nipah
viru
outbreak
respect
recent
earli
recognit
novel
coronaviru
associ
sar
diagnosi
emerg
transplantassoci
infect
advantag
approach
viral
particl
may
demonstr
neg
stain
thin
section
em
either
directli
clinic
materi
amplif
cell
cultur
like
cultur
em
limit
narrow
specif
reagent
prior
clinic
bia
fig
filament
spheric
shape
evenli
space
spike
cover
entir
viru
surfac
contain
hemagglutinin
neuraminidas
surfac
glycoprotein
f
human
metapneumoviru
paramyxovirus
heterogen
size
shape
rang
size
jlm
diamet
g
parainfluenza
viru
anoth
paramyxoviru
viral
nucleocapsid
typic
herringbon
appear
seen
within
stainpenetr
particl
well
partial
extrud
virion
import
featur
help
distinguish
paramyxovirina
parainfluenza
measl
virus
pneumovirina
human
metapneumoviru
respiratori
syncyti
viru
diamet
nucleocapsid
measur
respect
h
sever
acut
respiratori
syndrom
sar
coronaviru
particl
name
characterist
crownlik
fring
surfac
scale
bar
b
f
h
courtesi
c
humphrey
c
g
courtesi
e
palmer
e
courtesi
ea
murphi
center
diseas
control
prevent
atlanta
ga
adenovirus
first
cultur
identifi
earli
investig
search
etiolog
agent
acut
respiratori
infect
initi
adenoviru
isol
made
serendipit
adenoid
tissu
obtain
children
effort
establish
primari
human
adenoid
cell
line
relat
viru
identifi
follow
year
investig
studi
respiratori
diseas
militari
recruit
agent
subsequ
name
adenovirus
origin
sourc
tissu
prototyp
strain
identifi
adenovirus
non
envelop
virus
singl
linear
doublestrand
dna
genom
contain
within
icosahedr
capsid
measur
diamet
fig
ilia
capsid
compris
seven
known
polypeptid
includ
hexon
capsomer
contain
groupspecif
antigen
determin
adenovirus
ubiquit
divers
group
virus
found
natur
upper
respiratori
tract
gastrointestin
system
human
mammal
bird
adenovirus
infect
mucos
epithelium
although
pathogen
anim
trophic
endotheli
cell
endotheli
infect
identifi
immunocompromis
human
adenovirus
repres
least
serotyp
basi
resist
neutral
antisera
known
adenoviru
serotyp
compris
six
subgroup
subgenera
f
distinguish
differenti
hemagglutin
erythrocyt
variou
anim
speci
known
adenoviru
serotyp
associ
human
diseas
upper
lower
respiratori
tract
conjunctiva
urinari
tract
intestin
occasion
heart
liver
central
nervou
system
other
rare
encount
mayor
may
act
pathogen
recogniz
diseas
estim
approxim
pneumonia
infant
young
children
caus
adenovirus
pediatr
case
adenoviru
pneumonia
occur
month
year
age
serotyp
member
b
subgenu
common
caus
pneumonia
patient
cohort
serotyp
particularli
pathogen
adenovirus
caus
dissemin
often
fatal
diseas
previous
healthi
children
adult
pneumonia
gener
associ
serotyp
period
epidem
adenoviru
pneumonia
young
adult
identifi
particularli
among
militari
recruit
manner
similar
pathogen
adenovirus
take
advantag
impair
destroy
immun
system
establish
persist
dissemin
infect
immunocompromis
host
patient
cohort
sr
zaki
cd
paddock
case
fatal
rate
adenovir
pneumonia
approach
compar
approxim
mortal
immunocompet
patient
immunocompromis
patient
also
suscept
broader
rang
differ
adenoviru
serotyp
exampl
commonli
recogn
serotyp
normal
children
account
adenoviru
serotyp
report
children
congenit
immun
defici
adenovirus
establish
latenc
lymphoid
tissu
kidney
host
believ
mani
possibl
case
clinic
diseas
caus
adenovirus
immunocompromis
patient
reactiv
infect
lung
patient
adenoviru
pneumonia
typic
heavi
edemat
bronchi
gener
fill
mucoid
fibrin
purul
exud
histopatholog
find
fig
includ
necrot
bronchiti
bronchiol
extens
denud
ofth
surfac
epithelium
particularli
mediums
diamet
intrapulmonari
bronchi
fig
affect
airway
may
occlud
homogen
eosinophil
materi
mix
inflammatori
cell
detach
epithelium
cellular
debri
lamina
propria
bronchi
bronchiol
typic
congest
infiltr
predominantli
mononuclear
inflammatori
cell
infiltr
bronchial
serou
mucou
gland
also
often
involv
show
necrosi
mix
infiltr
infect
progress
involv
pulmonari
parenchyma
form
bronchocentr
necrosi
hemorrhag
neutrophil
mononuclear
cell
infiltr
karyorrhexi
find
gener
occur
background
exud
diffus
alveolar
damag
fill
air
space
macrophag
fibrin
detach
pneumocyt
hyalin
membran
format
patient
fatal
pneumonia
may
develop
dissemin
intravascular
coagulopathi
demonstr
fibrin
thrombi
vessel
lung
kidney
heart
adren
central
nervou
system
see
fig
chapter
adenovirus
form
intranuclear
inclus
respiratori
epitheli
cell
trachea
bronchi
bronchiol
acinar
cell
bronchial
gland
alveolar
pneumocyt
gener
abund
viabl
edg
necrot
foci
use
hematoxylin
eosin
h
e
stain
earli
inclus
appear
small
dens
amphophil
structur
surround
clear
zone
peripher
margin
chromatin
similar
herpet
inclus
cellular
infect
progress
inclus
becom
larger
larg
cell
basophil
margin
nuclear
membran
becom
blur
form
characterist
smudg
cell
fig
c
tracheal
aspir
patient
adenoviru
pneumonia
may
show
distinct
featur
cytolog
prepar
includ
cell
fine
strand
chromatin
radiat
central
inclus
margin
chromatin
nuclear
membran
rosett
cell
cell
foami
honeycomb
nuclei
well
typic
smudg
cell
see
fig
chapter
variou
method
use
diagnos
adenoviru
infect
includ
antigen
detect
cell
cultur
electron
microscopi
molecular
assay
serolog
direct
detect
techniqu
identifi
common
groupreact
hexon
antigen
tissu
bodi
fluid
includ
fluoresc
antibodi
assay
enzym
immunohistochemistri
stain
method
use
success
detect
adenovirusinfect
cell
formalinfix
paraffinembed
tissu
use
variou
commerci
avail
adenoviru
groupspecif
antibodi
f
electron
microscopi
adenovirusinfect
tissu
reveal
paracrystallin
array
virion
fig
adenovirus
isol
cell
cultur
bronchial
wash
tracheal
aspir
lung
biopsi
specimen
earli
stage
ill
grow
well
variou
cell
line
includ
human
embryon
kidney
hela
cell
cell
cultur
infect
adenovirus
exhibit
rel
characterist
cytopatholog
effect
describ
cluster
grape
within
day
inocul
serotyp
isol
accomplish
use
hemagglutin
inhibit
neutral
test
hyperimmun
typespecif
anim
antisera
molecular
assay
particularli
gene
amplif
use
pcr
ish
method
develop
detect
adenoviru
nucleic
acid
respiratori
secret
formalinfix
paraffinembed
tissu
broadrang
sensit
assay
detect
adenoviru
amplifi
common
genom
sequenc
eg
hexon
gene
region
specif
assay
detect
specif
adenoviru
type
uniqu
genom
sequenc
serolog
assay
includ
test
groupspecif
antibodi
e
g
complement
fixat
enzym
immunoassay
typespecif
antibodi
eg
neutral
hemagglutinationinhibit
assay
pitfal
associ
serolog
test
adenovirus
includ
occasion
rise
heterotyp
antibodi
typespecif
assay
use
rel
low
sensit
demonstr
complement
fixat
assay
human
hantavir
diseas
caus
group
close
relat
triseg
negativesens
rna
virus
genu
hantaviru
famili
bunyavirida
member
genu
hantaviru
similar
morpholog
featur
viru
particl
diamet
gener
appear
spheric
ovoid
although
pleomorph
form
may
seen
lipid
envelop
contain
glycoprotein
spike
surround
core
consist
genom
associ
protein
nucleocapsid
sr
zaki
cd
paddock
arrang
delic
tangl
filament
show
occasion
granul
presenc
characterist
inclus
bodi
thin
section
electron
microscopi
uniqu
gridlik
pattern
negativestain
electron
microscopi
differenti
virus
member
famili
bunyavirida
fig
sever
diseas
type
larg
depend
viral
serotyp
two
categori
hantavirusassoci
ill
describ
hemorrhag
fever
renal
syndrom
hfr
diseas
kidney
primarili
involv
hantaviru
pulmonari
syndrom
hp
diseas
lung
primarili
involv
isol
first
recogn
hantaviru
hantaan
viru
name
river
south
korea
subsequ
identif
caus
agent
hfr
report
death
sever
previous
healthi
individu
due
rapidli
progress
respiratori
diseas
southwestern
unit
state
etiolog
link
previous
unrecogn
hantaviru
clinic
diseas
differ
hfr
pronounc
pulmonari
involv
higher
mortal
rate
known
hp
hantavirusassoci
diseas
primarili
affect
blood
vessel
result
differ
degre
gener
capillari
dilat
edema
contrast
sever
hfr
abund
proteinrich
gelatin
retroperiton
edema
fluid
found
hp
patient
larg
bilater
pleural
effus
heavi
edemat
lung
fatal
far
eastern
hfr
distinct
triad
hemorrhag
necrosi
seen
renal
medullari
junction
zone
cardiac
right
atrium
anterior
pituitari
howev
patient
hp
hemorrhag
rare
ischem
necrot
lesion
except
attribut
shock
seen
histolog
morpholog
chang
endothelium
uncommon
seen
consist
promin
swollen
endotheli
cell
vascular
thrombi
endotheli
cell
necrosi
rare
hfr
sever
characterist
microscop
lesion
involv
kidney
howev
interstiti
pneumon
also
seen
fatal
case
contrast
microscop
chang
north
south
american
hp
princip
seen
lung
spleen
lung
show
mild
moder
interstiti
pneumon
character
variabl
degre
edema
interstiti
mononuclear
cell
infiltr
compris
mixtur
small
enlarg
mononuclear
cell
appear
immunoblast
focal
hyalin
membran
compos
condens
proteinac
intraalveolar
edema
fluid
fibrin
variabl
number
inflammatori
cell
observ
fig
typic
neutrophil
scanti
alveolar
pneumocyt
intact
evid
cellular
debri
nuclear
fragment
hyperplasia
fatal
case
prolong
surviv
interv
tissu
show
featur
characterist
exud
prolif
stage
diffus
alveolar
damag
lung
biopsi
taken
patient
surviv
ill
appear
similar
prolifer
repar
type
ii
pneumocyt
sever
edemat
fibroblast
thicken
alveolar
septa
sever
airspac
disorgan
distort
lung
architectur
see
chapter
characterist
microscop
find
hp
case
includ
variabl
number
immunoblast
within
splenic
red
pulp
periarteriolar
white
pulp
lymph
nodal
paracort
zone
hepat
portal
triad
peripher
blood
fig
e
similarli
sever
hfr
case
larg
mononuclear
cell
present
spleen
lymph
node
blood
hepat
portal
triad
electron
microscop
studi
hp
lung
tissu
demonstr
infect
endotheli
cell
macrophag
viru
viruslik
particl
observ
infrequ
extrem
difficult
identifi
autopsi
tissu
consider
degre
viral
pleomorph
postmortem
deterior
tissu
howev
typic
hantavir
inclus
seen
frequent
ident
confirm
immunolabel
fig
g
similar
inclus
observ
epitheli
cell
hfr
consid
ultrastructur
marker
hantavirusinfect
cell
use
immunohistochemistri
viral
antigen
found
primarili
within
capillari
endothelium
throughout
variou
tissu
hp
hfr
hp
mark
accumul
hantavir
antigen
pulmonari
microvasculatur
splenic
lymph
nodal
follicular
dendrit
cell
fig
despit
extens
endotheli
cell
accumul
hantavir
antigen
littl
ultrastructur
evid
cytopath
effect
hantaviru
pulmonari
syndrom
suspect
case
adult
respiratori
distress
syndrom
ard
without
known
precipit
caus
among
previous
healthi
individu
level
suspicion
particularli
high
patient
known
exposur
rodent
area
peromyscu
maniculatu
reservoir
hantaviru
found
physician
need
differenti
hp
common
acut
respiratori
diseas
pneumococc
pneumonia
influenza
viru
unexplain
ard
diagnosi
hp
suspect
patient
histori
clinic
manifest
also
support
histopatholog
although
singl
pathognomon
lesion
would
permit
certain
histopatholog
diagnosi
hp
overal
constel
histopatholog
hematolog
find
suggest
diseas
need
distinguish
patholog
hp
includ
rel
larg
number
differ
viral
rickettsi
bacteri
infect
well
variou
noninfecti
diseas
process
virusspecif
diagnosi
confirm
achiev
serolog
pcr
hantaviru
rna
ihc
hantavir
antigen
serolog
test
detect
hantavirusspecif
immunoglobulin
rise
sr
zaki
cd
paddock
titer
immunoglobulin
g
patient
sera
consid
method
choic
laboratori
confirm
hp
immunofluoresc
assay
enzymelink
immunosorb
assay
elisa
demonstr
presenc
specif
antihantavir
antibodi
current
use
rapid
diagnost
test
provid
result
within
hour
recent
synthet
hantavir
nucleocapsid
protein
use
improv
sensit
specif
serolog
assay
protein
avail
inactiv
hantavir
antigen
polymeras
chain
reaction
detect
viral
rna
blood
tissu
extrem
use
diagnost
epidemiolog
purpos
hantavir
rna
also
detect
formalinfix
paraffinembed
archiv
tissu
reversetranscriptas
rt
immunohistochemistri
test
formalinfix
tissu
use
detect
hantaviru
antigen
sensit
method
confirm
hantavir
infect
uniqu
role
diagnosi
fatal
hp
case
serum
sampl
frozen
tissu
unavail
formalinfix
autopsi
tissu
obtain
sever
acut
respiratori
syndrom
caus
agent
sar
envelop
positivestrand
rna
viru
member
genu
coronaviru
famili
coronavirida
corona
virus
largest
genom
rna
virus
replic
uniqu
mechan
result
high
frequenc
recombin
matur
sar
coronaviru
sarsco
v
similar
featur
previous
describ
coronavirus
form
align
helic
nucleocapsid
along
membran
endoplasm
reticulum
golgi
complex
acquir
envelop
bud
cisterna
cellular
vesicl
becom
fill
virion
progress
cell
surfac
releas
viru
particl
larg
number
particl
remain
adher
plasma
membran
cell
surfac
sever
acut
respiratori
syndrom
recogn
global
outbreak
sever
pneumonia
began
late
guangdong
provinc
china
gain
promin
earli
case
identifi
two
dozen
countri
asia
europ
north
america
south
america
diseas
caus
influenzalik
ill
fever
cough
dyspnea
headach
sever
case
caus
death
human
persontoperson
transmiss
combin
intern
travel
infect
person
acceler
worldwid
spread
ill
sever
report
describ
diffus
alveolar
damag
variou
level
progress
sever
main
histopatholog
find
sar
patient
fig
b
lung
typic
show
chang
describ
prolif
phase
diffus
alveolar
damag
hyalinemembran
format
desquam
epitheli
cell
fibrin
deposit
alveolar
space
hyperplasia
type
pneumocyt
increas
mononuclear
infiltr
interstitium
seen
case
find
identifi
patient
includ
focal
intra
alveolar
hemorrhag
necrot
inflammatori
debri
small
airway
organ
pneumonia
addit
multinucl
syncyti
cell
may
seen
intraalveolar
space
patient
die
day
onset
ill
fig
infect
coronavirus
includ
sarsco
v
known
induc
cell
fusion
cultur
produc
syncyti
cell
similar
sometim
observ
lung
patient
die
sar
cell
contain
abund
vacuol
cytoplasm
cleav
convolut
nuclei
without
obviou
intranuclear
intracytoplasm
viral
inclus
ish
ihc
studi
tissu
sar
patient
identifi
corona
viru
infect
upper
airway
bronchiolar
epithelium
fig
infect
ciliat
columnar
epitheli
cell
seen
focal
line
epithelium
trachea
larger
bronchi
fig
mani
infect
cell
slough
epithelium
observ
use
ish
within
bronchial
lumen
abund
viral
antigen
also
found
distribut
focal
parenchyma
lung
patient
seen
predominantli
cytoplasm
pneumocyt
occasion
macrophag
associ
intra
alveolar
necrot
debri
fibrin
fig
doublestain
studi
indic
sarsco
vinfect
cell
type
pneumocyt
doublestain
studi
also
detect
viral
nucleic
acid
distribut
similar
seen
ihc
studi
mainli
pneumocyt
macrophageslooelectron
microscop
examin
lung
tissu
select
area
abund
ihc
stain
show
numer
coronaviru
particl
nucleocapsid
inclus
virion
seen
cytoplasm
vesicl
along
cell
membran
pneumocyt
phagosom
macrophag
associ
fibrin
alveolar
space
corona
viru
particl
may
confus
morpholog
non
viral
cellular
compon
definit
ultrastructur
identif
achiev
use
immunogold
label
electron
microscopi
primari
histopatholog
lesion
seen
lung
patient
die
sar
somewhat
nonspecif
also
seen
acut
lung
injuri
case
caus
infecti
agent
trauma
drug
toxic
chemic
multinucl
syncyti
cell
similar
seen
sar
patient
also
found
number
viru
infect
includ
measl
parainfluenza
virus
rsv
nipah
viru
infect
earli
studi
four
human
sar
viral
antigen
detect
lung
ihe
like
explan
patient
studi
clinic
cours
aversr
zaki
cd
paddock
age
week
mani
viru
infect
viral
antigen
nucleic
acid
clear
within
week
diseas
onset
host
immun
respons
also
possibl
pulmonari
damag
associ
sar
caus
directli
viru
repres
secondari
effect
cytokin
factor
induc
viru
infect
similarli
influenza
viru
infect
viral
antigen
seen
predominantli
respiratori
epitheli
cell
larg
airway
rare
identifi
pulmonari
parenchyma
despit
concomit
occasion
sever
interstiti
pneumon
os
recent
report
shieh
et
al
chong
et
tempor
relationship
durat
ill
clearanc
sarsco
v
human
lung
tissu
examin
viral
antigen
nucleic
acid
detect
pulmonari
tissu
patient
die
earli
diseas
develop
specif
ihc
ish
immunoelectron
microscopi
iem
assay
identifi
sarsco
v
formalinfix
paraffinembed
sampl
facilit
assess
cellular
tropism
sarsco
v
infect
human
lung
tissu
local
sarsco
v
lung
occur
mainli
cytoplasm
pneumocyt
primarili
type
occasion
alveolar
macrophag
fig
type
pneumocyt
known
secret
pulmonari
surfact
result
reduc
surfac
tension
preserv
integr
alveolar
space
cell
also
play
import
role
tissu
restitut
follow
lung
damag
moreov
mount
evid
support
contribut
develop
acut
inflammatori
lung
injuri
follow
exposur
biolog
chemic
agent
addit
studi
need
defin
role
type
pneumocyt
alveolar
macrophag
sarsco
v
infect
cynomolgu
macaqu
inocul
sarscov
develop
patholog
find
pneumonia
propos
anim
model
haagman
et
show
extens
sarsco
v
antigen
express
experiment
infect
macaqu
day
infect
antigen
mainli
alveolar
line
epitheli
cell
morpholog
characterist
type
pneumocyt
indic
type
pneumocyt
primari
target
sarsco
v
infect
earli
diseas
type
pneumocyt
normal
repres
alveolar
epitheli
cell
volum
easili
damag
pulmonari
infect
type
injuri
recent
studi
nonhuman
evid
infect
type
pneumocyt
addit
type
pneumocyt
macrophag
found
small
anim
model
rodent
would
use
evalu
vaccin
immunotherapi
antivir
drug
recent
identifi
mous
anim
model
purpos
studi
microscop
examin
trachea
bronchu
lung
thymu
heart
day
infect
reveal
mild
focal
peri
bronchiolar
mononuclear
inflammatori
infiltr
signific
histopatholog
chang
organ
viral
antigen
nucleic
acid
focal
distribut
bronchiolar
epitheli
cell
virion
found
area
ultrastructur
analysi
data
suggest
sarsco
v
replic
mice
titer
suffici
evalu
vaccin
antivir
agent
mous
small
anim
model
might
also
use
test
abil
viru
replic
caus
diseas
facilit
identif
hostimmun
mechan
contribut
resolut
sarsco
v
infect
cytomegalovirus
cmv
compris
distinct
ancient
group
herpesvirus
wide
distribut
natur
share
similar
growth
characterist
cell
cultur
caus
cellular
enlarg
form
distinct
inclus
infect
cell
cytopath
chang
identifi
earli
pathologist
salivari
gland
children
die
variou
unrel
led
earli
design
cytomegal
inclus
diseas
mani
year
caus
agent
isol
name
cytomegaloviru
propos
reflect
cytopath
chang
caus
virus
cytomegalovirus
highli
hostspecif
variou
mammalian
host
includ
nonhuman
primat
rodent
domest
anim
infect
distinct
cmi
context
human
cmv
stringent
speciesspecif
rare
except
infect
cell
human
origin
sever
cell
type
permiss
cmv
replic
includ
alveolar
pneumocyt
vascular
endothelium
fibroblast
monocyt
dendrit
cell
exocrin
endocrin
glandular
epitheli
cytomegaloviru
herpesviru
largest
genom
kilobas
pair
kbp
herpesvirus
known
infect
human
doublestrand
linear
dna
genom
contain
within
icosahedr
capsid
surround
amorph
materi
known
tegument
compon
enclos
lipid
bilay
envelop
deriv
host
cell
nuclear
golgi
membran
contain
sever
vir
alli
encod
glycoprotein
necessari
infect
cell
matur
envelop
virion
rang
make
cmv
one
largest
virus
infect
human
fig
structur
cmv
typic
human
herpesvirus
demonstr
subtl
ultrastructur
differ
virus
group
includ
greater
pleomorph
lipid
envelop
dens
bodi
inclus
cytoplasm
infect
cytomegaloviru
ubiquit
human
pathogen
north
america
infect
approxim
infect
inappar
although
case
primari
infect
otherwis
healthi
individu
result
selflimit
mononucleosi
syndrom
similar
caus
epsteinbarr
viru
estim
case
heterophileneg
mononucleosi
case
mononucleosi
caus
cmi
pulmonari
involv
cmv
mononucleosi
infrequ
occur
approxim
casesyo
congenit
acquir
cmv
infect
variou
deleteri
effect
fetu
includ
mental
retard
neurolog
abnorm
sensorineur
hear
loss
retin
one
seri
pulmonari
involv
occur
symptomat
infant
like
herpesvirus
cmv
remain
host
life
primari
infect
establish
latenc
variou
cell
type
includ
vascular
endotheli
cell
monocyt
macrophag
neutrophil
renal
pulmonari
epitheli
cell
activ
viral
replic
occur
person
sever
compromis
immun
patient
advanc
hiv
diseas
recipi
hematopoiet
stem
cell
lung
transplant
particularli
risk
develop
cmv
pneumonia
use
cmv
screen
effect
antivir
prophylaxi
regimen
patient
undergo
allogen
bone
marrow
transplant
leukemia
solid
organ
transplant
develop
cmv
pneumonia
case
fatal
rate
greater
seri
rel
high
frequenc
cmv
pneumonia
lung
transplant
recipi
may
correl
anim
model
data
indic
lung
major
site
latent
cmv
infect
use
ganciclovir
therapi
cmv
diseas
aid
patient
case
fatal
rate
cmv
pneumonia
patient
cohort
cmv
pathogen
identifi
mix
infect
cmv
anoth
pathogen
even
wors
prognosi
case
fatal
rate
patient
pulmonari
diseas
caus
cmv
pneumocysti
jiroveci
formerli
carinii
cytomegaloviru
pneumonia
show
variou
histopatholog
pattern
fig
extens
intra
alveolar
hemorrhag
scatter
cytomegal
cell
rel
inflammatori
cell
infiltr
may
occur
fig
similar
manner
extens
involv
alveolar
epithelium
minim
inflamm
overt
evid
parenchym
injuri
also
describ
pattern
includ
multifoc
lesion
mix
inflammatori
cell
infiltr
hemorrhag
necrosi
cytomegal
cell
diffus
predominantli
mononuclear
cell
infiltr
interstiti
pneumon
intraalveolar
edema
fibrin
deposit
diffus
distribut
cytomegal
cell
fig
cytomegal
chang
cmvinfect
cell
evid
standard
h
e
stain
virtual
pathognomon
activ
cmv
infect
cell
enlarg
j
contain
amphophil
deepli
basophil
intranuclear
intracytoplasm
inclus
fig
e
singl
intranuclear
inclus
compos
viral
nucleoprotein
assembl
cap
id
larg
j
round
ovoid
bodi
smoothli
contour
border
gener
surround
clear
halo
give
inclus
distinct
owlsey
appear
host
cell
nucleolu
often
retain
inclus
cytoplasm
inclus
small
j
granular
bodi
appear
intranuclear
inclus
well
develop
uniformli
present
cmvinfect
cell
fig
inclus
repres
mixtur
virion
variou
cellular
organel
increas
size
number
infect
progress
unlik
intranuclear
inclus
cytoplasm
inclus
stain
period
acidschiff
stain
deepli
argyrophil
gomori
methenamin
silver
stain
cytomegaloviru
pneumonia
defin
presenc
sign
symptom
pulmonari
diseas
combin
detect
cmv
bronchoalveolar
lavag
bal
fluid
lung
tissu
sampl
context
detect
method
support
definit
includ
viru
isol
histopatholog
observ
cytomegal
cell
ish
ihc
stain
fig
detect
pcr
alon
consid
sensit
diagnosi
cmv
pneumonia
insuffici
purpos
cytomegaloviru
often
cultur
human
diploid
fibroblast
human
embryon
lung
human
foreskin
fibroblast
grow
slowli
convent
cell
cultur
cytopath
effect
gener
detect
second
week
longer
inocul
reason
shell
vial
method
use
centrifug
enhanc
infect
becom
standard
isol
techniqu
usual
yield
diagnost
result
within
hour
centuri
term
herp
deriv
greek
erpein
crawl
use
medicin
describ
spread
cutan
lesion
end
centuri
investig
surmis
herpet
lesion
lip
genitalia
manifest
singl
infecti
agent
recogn
diseas
distinct
herp
zoster
human
herpesvirus
hsv
larg
envelop
doublestrand
dnacontain
virion
icoshedr
nucleocapsid
approxim
diamet
compos
cap
somer
nucleocapsid
surround
amorph
sometim
asymmetr
materi
tegument
surround
thin
trilaminar
envelop
contain
numer
glycoprotein
spike
fig
assembl
hsv
begin
nucleu
host
cell
viru
acquir
envelop
capsid
bud
inner
lamella
nuclear
two
serolog
type
recogn
frequent
associ
particular
diseas
syndrom
howev
either
serotyp
may
caus
aggreg
clinic
syndrom
herp
simplex
caus
gingivostomat
pharyng
esophag
keratoconjunct
enceph
serotyp
commonli
associ
adult
hsv
pneumonia
herp
simplex
typic
infect
genit
site
peni
urethra
vulva
vagina
cervix
serotyp
associ
approxim
dissemin
diseas
pulmonari
infect
newborn
infant
herpesvirus
abil
persist
inact
state
vari
period
time
recur
spontan
follow
undefin
stimuli
associ
physic
emot
stress
trauma
nerv
root
ganglia
fever
immunosuppress
exposur
ultraviolet
radiat
primari
infect
hsv
replic
portal
entri
typic
oral
genit
mucosa
infect
sensori
nerv
end
viru
transport
centripet
along
peripher
sensori
nerv
central
axon
final
nerv
cell
bodi
trigemin
sacral
vagal
ganglia
replic
briefli
becom
antivir
drug
effect
latent
infect
hsv
follow
cue
initi
viral
reactiv
hsv
replic
sensori
ganglia
transport
centrifug
along
sensori
nerv
epitheli
cell
mucos
surfac
reactiv
hsv
trigemin
ganglion
associ
asymptomat
excret
viru
saliva
develop
herpet
ulcer
vermillion
border
lip
oral
mucosa
extern
facial
skin
newborn
infant
sever
immunosuppress
burn
patient
patient
sever
trauma
greatest
risk
develop
hsv
lower
respiratori
tract
diseas
neonat
commonli
associ
dissemin
herpet
infect
dissemin
hsv
infect
newborn
first
describ
hepatoadren
necrosi
promin
frequent
necros
occur
liver
adren
gland
affect
neonat
case
neonat
diseas
repres
primari
hsv
infect
acquir
parturit
hsvinfect
mother
incid
neonat
hsv
infect
approxim
deliveri
dissemin
diseas
develop
approxim
infect
neonat
dissemin
infect
sign
symptom
appear
mean
day
birth
rang
day
approxim
patient
develop
pneumonia
pre
antivir
era
neonat
dissemin
diseas
die
infect
earli
diagnosi
highdos
acyclovir
therapi
mortal
reduc
approxim
diseas
exceedingli
difficult
diagnos
time
manner
mother
affect
infant
clinic
appar
hsv
infect
time
neonat
surviv
sever
dissemin
diseas
may
develop
hepat
adren
calcif
evid
abdomin
radiograph
adult
infect
respiratori
tract
hsv
may
associ
dissemin
herpet
infect
commonli
identifi
isol
diseas
manifest
result
reactiv
latent
herpet
infect
oropharynx
herpet
tracheobronch
ulcer
process
character
larg
area
denud
mucos
epithelium
fibrinopurul
exud
contain
necrot
cell
dens
eosinophil
cytoplasm
despit
extens
tissu
damag
cell
intranuclear
inclus
may
spars
identifi
found
often
margin
ulcer
epithelium
occasion
mucou
gland
subjac
ulcer
surfac
aspir
viruscontain
secret
lower
respiratori
tract
believ
frequent
caus
pulmonari
infect
hsv
howev
oral
lesion
may
absent
patient
herpet
laryngotracheobronch
bronchopneumonia
diseas
also
associ
airway
trauma
caus
tracheal
intub
hematogen
dissemin
hsv
chest
radiograph
hsv
pneumonia
gener
show
illdefin
nodular
reticular
densiti
variou
size
scatter
lung
field
earli
stage
diseas
nodul
measur
mm
best
seen
peripheri
lung
diseas
progress
lesion
coalesc
enlarg
form
extens
infiltr
herpet
infect
airway
lung
characterist
difficult
diagnos
clinic
hsv
pneumonia
describ
distinct
clinic
entiti
sever
studi
attest
rel
infrequ
diagnosi
consid
patient
respiratori
diseas
exampl
none
case
hsv
diseas
middl
lower
respiratori
tract
identifi
review
autopsi
brook
armi
medic
center
suspect
prior
autopsi
review
cultureconfirm
case
hsv
pneumonia
none
patient
diagnos
prior
death
oral
herpet
lesion
time
recent
investig
also
suggest
lower
respiratori
tract
diseas
caus
hsv
may
common
current
appreci
studi
sweden
hsv
cultur
pro
diagnosi
tracheobronch
pneumonia
best
establish
histolog
fig
lower
respiratori
tract
hsv
infect
often
focus
tracheobronchi
tree
open
lung
biopsi
may
less
sensit
herpet
lesion
show
extens
necrosi
karyorrhect
debri
associ
hemorrhag
sparsetomoder
neutrophil
infiltr
fig
b
intranuclear
inclus
best
appreci
cell
lead
edg
necrot
foci
fig
c
inclus
appear
either
homogen
amphophil
glassi
cowdri
type
b
inclus
eosinophil
halo
separ
inclus
nuclear
membran
ie
cow
dri
type
inclus
cowdri
type
b
inclus
contain
activ
replic
viru
type
inclus
consid
noninfecti
devoid
viral
nucleic
acid
protein
repres
nuclear
scar
hsv
infect
chang
associ
hsv
includ
multi
nucleat
nuclear
mold
balloon
degener
cytoplasm
frequent
associ
squamou
epithelium
seldom
encount
lung
high
frequenc
hepat
adren
involv
dissemin
hsv
infect
young
children
fig
g
liver
biopsi
suggest
diagnost
techniqu
patient
cohort
commerci
avail
antibodi
exist
ihc
detect
hsv
tissu
fig
viru
isol
remain
import
diagnost
method
howev
hsv
isol
oropharyng
secret
occasion
lower
respiratori
tract
patient
lack
overt
pulmonari
diseas
virolog
cultur
must
interpret
context
complementari
clinic
radiograph
histopatholog
find
much
possibl
cell
cultur
system
suscept
hsv
includ
vero
cell
foreskin
fibroblast
cytopath
effect
gener
develop
within
hour
cultur
inocul
infecti
specimen
suitabl
specimen
includ
scrape
made
mucocutan
lesion
tracheobronchi
aspir
bal
specimen
infant
evid
hepat
may
also
use
obtain
duoden
aspir
hsv
isol
polymeras
chain
reaction
method
amplifi
hsv
dna
clinic
specimen
includ
tissu
blood
particularli
use
specif
distinguish
hsvl
varicellazost
viru
vzv
also
known
human
herpesviru
human
aherpesviru
close
relat
hsv
linear
doublestrand
dna
genom
approxim
kbp
encod
protein
icosahedr
nucleocapsid
indistinguish
appear
herp
virus
nucleocapsid
tegument
surround
lipoprotein
envelop
deriv
host
cytoplasm
membran
envelop
viral
particl
pleomorph
spheric
shape
diamet
primari
infect
initi
inocul
respiratori
mucosa
viru
infecti
aerosol
direct
contact
skin
lesion
patient
varicella
herp
zoster
primari
viremia
reticuloendotheli
system
secondari
viremia
circul
mononuclear
cell
viru
dissemin
skin
initi
vesicular
rash
back
mucos
site
lung
releas
infecti
viru
respiratori
droplet
pathogen
characterist
distinguish
vzv
human
herpesvirus
attack
rate
previous
uninfect
household
contact
expos
varicella
approxim
less
sustain
exposur
estim
approxim
primari
infect
vzv
viral
replic
keratinocyt
fig
vascular
lymphat
endotheli
cell
superfici
dermi
produc
gener
prurit
vesicular
rash
varicella
commonli
known
chickenpox
varicellazost
viru
also
establish
latent
infect
within
satellit
cell
neuron
trigemin
dorsal
root
ganglia
reactiv
variou
condit
caus
herp
zoster
pain
vesicular
rash
commonli
refer
shingl
origin
term
chickenpox
specul
believ
deriv
gican
old
english
term
itch
term
shingl
origin
mediev
latin
cingul
girdl
allud
partial
encircl
trunk
rash
herp
zoster
varicellazost
viru
ubiquit
human
popul
around
world
human
known
host
prevaccin
era
us
approxim
million
case
hospit
death
report
risk
sever
ill
primari
recurr
vzv
infect
appear
depend
host
factor
rather
particular
viral
strain
chickenpox
consid
rel
benign
infect
children
adult
patient
approxim
time
like
children
develop
pneumonia
greatest
risk
sever
diseas
pneumonia
occur
patient
chronic
lung
diseas
immunesuppress
condit
neonat
pregnant
women
varicellazost
virusrel
death
declin
sharpli
us
sinc
univers
childhood
vaccin
implement
sr
zaki
cd
paddock
varicella
pneumonia
first
describ
medic
literatur
frequent
report
complic
chickenpox
adult
patient
pneumonia
occur
approxim
adult
infect
vzv
occurr
pneumonia
herp
zoster
rare
limit
primarili
profoundli
immunosuppress
patient
particularli
bone
marrow
transplant
recipi
varicellazost
viru
pneumonia
gener
develop
within
day
follow
onset
rash
may
character
fever
cough
tachypnea
chest
pain
hemoptysi
hypoxemia
common
may
sever
radiograph
lung
show
multipl
scatter
defin
nodular
densiti
untreat
adult
varicella
pneumonia
fatal
approxim
case
mortal
high
certain
highrisk
cohort
includ
pregnant
women
transplant
recipi
neonat
massiv
pulmonari
hemorrhag
frequent
termin
event
gross
examin
reveal
lung
gener
two
three
time
heavier
normal
firm
plumcolor
often
multipl
necrot
hemorrhag
lesion
viscer
pleura
resembl
pox
lesion
skin
pox
may
also
seen
pariet
pleura
although
pleural
effus
uncommon
rare
promin
trachea
bronchi
gener
edemat
erythemat
occasion
vesicl
mucos
surfac
may
lobular
consolid
lung
microscop
pulmonari
involv
consist
primarili
interstiti
pneumon
diffus
miliari
foci
necrosi
hemorrhag
pulmonari
parenchyma
involv
alveolar
wall
blood
vessel
bronchiol
fig
find
may
includ
intraalveolar
collect
edema
fibrin
hemorrhag
diffus
alveolar
damag
septal
edema
viral
infect
cell
intranuclear
inclus
may
identifi
respiratori
epitheli
cell
pneumocyt
interstiti
fibroblast
capillari
endothelium
fig
f
eosinophil
intranuclear
inclus
multinucl
syncyti
cell
may
difficult
locat
best
identifi
edg
necrot
foci
fig
case
dissemin
diseas
similar
necrot
hemorrhag
lesion
occasion
viral
cytopath
chang
epitheli
cell
fibroblast
may
observ
tissu
organ
includ
esophagu
pancrea
liver
renal
pelv
uret
urinari
bladder
spleen
bone
marrow
thymu
lymph
node
adren
gland
brain
patient
recov
sever
vzv
pneumonia
necrot
parenchym
foci
may
miner
identifi
chest
radiograph
year
later
miliari
mm
nodular
opac
microscop
lesion
character
discret
collect
dens
fibrou
connect
tissu
surround
multipl
small
calcifi
bodi
peripheri
may
includ
cellular
zone
fibroblast
occasion
giant
radiograph
survey
person
identifi
pulmonari
calcif
eight
patient
chickenpox
adulthood
compar
eight
remain
report
varicella
adult
posit
histori
varicella
predict
immun
person
pulmonari
symptom
often
occur
sever
day
follow
onset
characterist
rash
varicella
patholog
diagnosi
seldom
requir
realtim
diagnosi
vzv
pneumonia
howev
hematopoiet
cell
transplant
recipi
may
present
sign
viscer
dissemin
pneumonia
day
local
cutan
erupt
herp
zoster
appear
lower
respiratori
tract
diseas
describ
absenc
skin
lesion
particularli
neonat
bone
marrow
transplant
recipi
commerci
avail
antigen
detect
kit
use
rapid
diagnosi
cutan
vzv
infect
epitheli
cell
scrape
base
newli
form
vesicl
appli
slide
stain
use
fluoresceinconjug
vzv
monoclon
antibodi
detect
specif
viral
protein
specimen
similar
manner
tzanck
test
use
wrightgiemsa
stain
demonstr
multinucl
giant
cell
specimen
howev
test
differenti
hsv
vzv
falseneg
result
common
commerci
avail
antibodi
also
avail
ihc
detect
vzv
tissu
specimen
fig
f
howev
rel
laboratori
abl
provid
wellvalid
assay
commerci
laboratori
offer
pcr
amplif
detect
viral
nucleic
acid
clinic
specimen
isol
viru
cell
cultur
remain
refer
standard
diagnosi
vzv
human
melanoma
cell
excel
substrat
vzv
isol
averag
time
visibl
cytopath
effect
viru
infecti
vzv
usual
recover
clear
fluid
cutan
vesicl
varicella
approxim
day
appear
lesion
approxim
week
herp
zoster
lesion
lung
common
organ
vzv
isol
autopsi
isol
also
obtain
heart
liver
pancrea
gastrointestin
tract
brain
eye
influenza
deriv
term
influentia
mean
epidem
italian
form
latin
origin
use
epidem
thought
result
astrolog
occult
influenc
influenza
highli
contagi
acut
respiratori
ill
spectrum
clinic
ill
rang
asymptomat
mild
diseas
rhiniti
pharyng
primari
viral
pneumonia
sr
zaki
cd
paddock
fatal
outcom
influenza
may
also
associ
broad
rang
disord
affect
heart
brain
kidney
muscl
influenzavirus
belong
orthomyxovirida
famili
consist
four
genera
includ
two
import
influenza
virus
type
b
associ
signific
human
diseas
influenza
virus
classifi
subtyp
base
antigen
hemagglutinin
ha
neuraminidas
na
surfac
glycoprotein
one
type
ha
one
type
na
recogn
influenza
b
influenza
occur
pandem
interpandem
form
fortun
pandem
defin
worldwid
outbreak
sever
diseas
occur
infrequ
interpandem
influenza
although
less
extens
impact
occur
virtual
everi
year
epidemiolog
pattern
influenza
human
relat
two
type
antigen
variat
envelop
glycoprotein
name
antigen
drift
antigen
shift
antigen
drift
new
strain
relat
circul
previou
epidem
evolv
accumul
point
mutat
surfac
glycoprotein
enabl
viru
evad
immun
system
lead
repeat
outbreak
interpandem
year
antigen
shift
occur
emerg
new
potenti
pandem
influenza
viru
possess
novel
ha
alon
combin
novel
na
recogn
ha
subtyp
nine
na
subtyp
influenza
viru
virus
ha
na
subtyp
recov
aquat
bird
three
ha
subtyp
hi
two
na
subtyp
nl
establish
stabl
lineag
human
popul
sinc
sinc
widespread
avian
infect
influenza
associ
cluster
human
diseas
arous
concern
threat
pandem
attent
appropri
focus
control
measur
deal
event
influenzavirus
segment
negativesens
rna
core
surround
lipid
envelop
influenzaviru
particl
pleomorph
among
isol
undergon
limit
number
passag
cell
cultur
egg
filament
spheric
particl
seen
spheric
morpholog
becom
domin
viru
extens
passag
laboratori
layer
ha
rodshap
na
mushroomshap
spike
project
radial
surfac
influenza
b
virus
hemagglutinin
facilit
entri
viru
host
cell
attach
sialicacid
receptor
neutral
antibodi
direct
antigen
critic
compon
current
influenza
vaccin
neuraminidas
second
major
antigen
determin
catalyz
cleavag
glycosid
linkag
sialic
acid
releas
progeni
virion
infect
cell
accordingli
becom
import
target
drug
inhibitor
oseltamivir
zanamivir
surfac
compon
channel
influenza
present
influenza
b
viru
regul
intern
ph
viru
block
antivir
drug
amantadin
influenzavirus
spread
persontoperson
primarili
cough
sneez
infect
person
typic
incub
period
influenza
day
averag
day
adult
infecti
day
symptom
begin
approxim
day
ill
onset
children
infecti
day
young
children
shed
viru
sever
day
ill
onset
sever
immunocompromis
person
shed
viru
week
month
uncompl
influenza
ill
character
abrupt
onset
constitut
respiratori
sign
symptom
eg
fever
myalgia
headach
malais
nonproduct
cough
sore
throat
rhiniti
among
children
otiti
media
nausea
vomit
also
commonli
report
influenza
ill
respiratori
ill
caus
influenza
difficult
distinguish
ill
caus
respiratori
pathogen
basi
symptom
alon
influenza
typic
resolv
day
patient
although
cough
malais
persist
week
among
certain
person
influenza
exacerb
underli
medic
condit
eg
pulmonari
cardiac
diseas
lead
secondari
bacteri
pneumonia
primari
influenza
viral
pneumonia
occur
part
coinfect
viral
bacteri
pathogen
young
children
influenza
infect
initi
symptom
mimic
bacteri
sepsi
children
hospit
influenza
febril
seizur
influenza
also
associ
encephalopathi
transvers
myeliti
rey
syndrom
myositi
myocard
pericard
risk
complic
hospit
death
influenza
higher
among
person
age
year
young
children
person
age
certain
underli
health
condit
among
healthi
older
children
younger
adult
influenzarel
death
result
pneumonia
exacerb
cardiopulmonari
condit
chronic
diseas
histopatholog
featur
nonfat
fatal
influenza
well
describ
includ
necrot
bronchiti
thrombosi
interstiti
inflamm
hemorrhag
hyalin
membran
format
intra
alveolar
edema
fig
b
c
patholog
promin
larger
bronchi
inflamm
may
vari
intens
individu
patient
viral
inclus
identifi
light
microscopi
fig
secondari
bacteri
infect
organ
streptococcu
pneumonia
group
streptococcu
ga
staphylococcu
aureu
haemophilu
influenza
may
occur
complic
fatal
case
make
difficult
recogn
patholog
chang
associ
primari
viral
tion
histopatholog
featur
organ
may
includ
myocard
cerebr
edema
rhabdomyolysi
hemophagocytosi
fig
f
immunohistochemistri
ish
assay
demonstr
viral
antigen
nucleic
acid
usual
spars
primarili
seen
bronchioepitheli
cell
larger
bronchiol
fig
e
f
antigen
readili
identifi
patient
die
within
day
onset
ill
recent
studi
suggest
unlik
human
influenza
virus
avian
viru
preferenti
infect
cell
lower
respiratori
tract
human
result
extens
damag
lung
minim
patholog
upper
respiratori
tract
fig
c
may
help
explain
avian
influenza
viru
lethal
human
difficult
spread
person
person
studi
show
avian
viru
preferenti
bind
receptor
found
around
alveoli
contrast
human
influenzavirus
preferenti
bind
found
throughout
respiratori
tract
nose
lung
bird
anim
viral
antigen
detect
lung
well
varieti
extrapulmonari
tissu
fig
diagnosi
influenza
suspect
histori
clinic
manifest
also
support
histopatholog
howev
absenc
characterist
viral
inclus
overal
patholog
featur
influenza
may
resembl
viral
rickettsi
certain
bacteri
infect
unequivoc
diagnosi
made
laboratori
test
viral
cultur
direct
fluoresc
antibodi
rapid
antigen
assay
serolog
ihc
measl
measl
rubeola
infecti
acut
febril
viral
ill
character
upper
respiratori
tract
symptom
fever
maculopapular
rash
caus
agent
member
genu
morbilliviru
famili
envelop
viru
contain
neg
sens
singlestrand
rna
genom
nucleotid
human
pathogen
famili
includ
parainfluenza
mump
respiratori
syncyti
virus
measl
virion
pleomorph
gener
spheric
envelop
particl
nm
diamet
viru
morpholog
indistinguish
member
paramyxovirida
famili
view
neg
contrast
electron
microscopi
lipid
envelop
surround
helic
nucleocapsid
compos
rna
protein
two
transmembran
glycoprotein
hemagglutinin
h
fusion
f
present
envelop
appear
surfac
project
protein
mediat
viral
attach
figur
influenza
alveolar
damag
patient
fatal
influenza
show
promin
congest
intraalveolar
macrophag
fibrin
deposit
b
extens
ulcer
respiratori
epithelium
larg
airway
patient
fatal
influenza
lamina
propria
show
florid
vascular
congest
focal
hemorrhag
predominantli
mononuclear
inflammatori
cell
infiltr
ce
immunohistochem
stain
c
e
influenza
viru
hemagglutinin
antigen
cytoplasm
residu
respiratori
epitheli
cell
larg
airway
focu
extens
infect
respiratori
epithelium
demonstr
unlik
mani
viral
respiratori
pathogen
influenza
virus
elicit
specif
cytopath
effect
infect
cell
f
insitu
hybrid
assay
fusion
respiratori
epithelium
also
believ
playa
role
viru
matur
interact
matrix
protein
turn
thought
interact
nucleocapsid
structur
measl
highli
communic
diseas
worldwid
distribut
introduct
measl
vaccin
epidem
occur
everi
year
percentag
nonimmun
member
popul
reach
critic
level
recent
epidem
occur
cycl
year
small
isol
commun
measl
circul
may
ceas
altogeth
unless
reintroduc
introduc
non
immun
popul
diseas
tend
sever
may
involv
popul
highli
infecti
natur
viru
although
still
signific
problem
underdevelop
countri
measl
infect
becam
uncommon
us
develop
widespread
use
effect
measl
vaccin
howev
recrudesc
measl
infect
occur
sever
larg
us
urban
center
recent
year
associ
reduc
use
vaccin
among
children
young
adult
peak
activ
ie
greater
measl
case
approxim
measlesassoci
death
report
measl
viru
highli
contagi
spread
aerosol
droplet
respiratori
secret
acut
less
frequent
contamin
fomit
involv
transmiss
person
acut
measl
infect
onset
symptom
defervesc
fever
develop
countri
like
set
exposur
measl
viru
infecti
diseas
clinic
pediatr
emerg
room
physician
offic
children
usual
infect
year
age
result
lifelong
immun
almost
adult
immun
clinic
infect
children
younger
month
age
gener
uncommon
passiv
protect
afford
infant
transfer
matern
antibodi
howev
resurg
measl
us
came
realiz
women
childbear
age
strate
activ
replic
influenza
respiratori
epithelium
larg
airway
g
electron
micrograph
influenza
particl
arrow
attach
cilia
rodent
tracheal
epitheli
cell
viral
ribonucleoprotein
evid
central
aspect
particl
hemagglutinin
neuraminidas
surfac
glycoprotein
make
peripher
spike
layer
courtesi
fa
murphi
h
rhabdomyolysi
patient
fatal
influenza
bar
b
h
h
e
c
e
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
f
digoxigeniniabel
probe
follow
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
g
uranyl
acet
lead
citrat
stain
acquir
immun
measl
vaccin
natur
infect
lower
level
matern
antibodi
found
transfer
immun
mother
infant
thu
substanti
number
measl
case
occur
children
younger
year
age
us
recent
year
incub
period
week
prodrom
phase
measl
begin
fever
rhinorrhea
cough
conjunct
koplik
spot
small
irregular
red
spot
bluishwhit
speck
center
appear
buccal
mucosa
case
shortli
rash
onset
erythemat
maculopapular
rash
begin
face
day
prodrom
symptom
usual
spread
trunk
extrem
symptom
gradual
resolv
rash
last
approxim
day
fade
order
appear
although
recoveri
rapid
complet
case
complic
aris
result
continu
progress
viru
replic
bacteri
viral
superinfect
abnorm
host
immun
respons
common
complic
secondari
bacteri
pneumonia
otiti
media
complic
includ
febril
convuls
enceph
liver
function
abnorm
chronic
diarrhea
sinus
sever
pulmonari
central
nervou
system
cn
syndrom
often
fatal
describ
death
occur
everi
measl
case
howev
risk
death
complic
substanti
increas
infant
adult
malnourish
immunocompromis
individu
person
underli
ill
nonimmun
popul
underdevelop
first
step
measl
infect
attach
viru
cell
surfac
receptor
respiratori
adhes
fusion
viru
respiratori
epithelium
mediat
hand
f
viral
glycoprotein
stage
follow
local
replic
respiratori
mucosa
drain
lymph
node
primari
viremia
follow
dissemin
two
type
multinucl
giant
cell
describ
patient
tissu
measl
infect
reticuloendotheli
giant
cell
warthinfinkeldey
appear
first
incub
period
seen
nucleu
pneumocyt
lung
patient
fatal
avian
influenza
unlik
influenza
virus
caus
diseas
human
preferenti
infect
alveolar
epitheli
cell
caus
rel
minim
patholog
upper
airway
h
e
b
c
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
differ
lymphoid
tissu
throughout
bodi
second
type
epitheli
giant
cell
observ
epithelium
essenti
everi
major
organ
onset
rash
tempor
coincid
appear
detect
serum
antibodi
measl
viru
interestingli
viru
replic
giant
cell
format
ceas
appear
rash
tcell
immun
essenti
process
viral
clearanc
lymphoid
tissu
respiratori
tract
children
congenit
agammaglobulinemia
respond
normal
measl
viru
infect
patient
cellmedi
immunodefici
develop
sever
diseas
present
giantcel
pneumonia
encephalopathi
absenc
exanthem
immun
f
surfac
glycoprotein
necessari
prevent
spread
measl
infect
atyp
measl
syndrom
character
pulmonari
consolid
pleural
effus
hilar
adenopathi
report
children
expos
wildtyp
measl
viru
previous
receiv
killedmeasl
viru
recipi
formalininactiv
vaccin
good
antibodi
respons
h
protein
antibodi
function
region
f
protein
nucleoprotein
weak
absent
suggest
lack
function
f
antibodi
respons
may
playa
role
viru
spread
patholog
featur
measl
well
describ
sever
refer
contain
detail
morpholog
descript
recommend
typic
morbilliform
skin
lesion
koplik
spot
measl
lymphaden
seldom
seen
surgic
pathologist
sinc
clinic
diagnosi
usual
appar
histopatholog
chang
skin
includ
mild
congest
edema
predominantli
mononuclear
infiltr
surround
small
vessel
dermi
well
nonspecif
featur
occasion
diagnost
multinucl
epitheli
giant
cell
eosinophil
cytoplasm
nuclear
inclus
observ
pathognomon
reticuloendotheli
multinucl
giant
cell
observ
appendix
specimen
patient
mistakenli
oper
acut
append
emerg
diagnost
koplik
spot
rash
cell
report
variou
lymphoreticular
tissu
throughout
bodi
typic
larg
contain
occasion
nuclei
cell
usual
contain
viral
inclus
lymphoid
tissu
typic
hyperplast
architectur
partial
total
obliter
diffus
prolifer
immunoblast
focal
gener
interstiti
pneumon
similar
seen
mani
viral
infect
seen
lung
measl
patient
histopatholog
featur
seen
includ
variou
degre
peribronchi
interstiti
mononuclear
cell
infiltr
squamou
metaplasia
bronchial
endothelium
prolifer
type
ii
pneumocyt
alveolar
line
cell
intraalveolar
edema
without
mononuclear
cell
exud
hyalin
membran
secondari
chang
bacteri
viral
superinfect
organiz
chang
may
alter
origin
patholog
hallmark
diseas
format
multinucl
epitheli
giant
cell
fig
lllla
b
cell
often
numer
form
fusion
bronchiolar
alveolar
line
epitheli
cell
contrast
reticuloendotheli
giant
cell
cell
gener
contain
characterist
nuclear
cytoplasm
inclus
intranuclear
inclus
homogen
eosinophil
surround
slight
indistinct
halo
fig
cytoplasm
inclus
deepli
eosinophil
vari
size
form
larg
mass
melt
tallow
appear
fig
giant
cell
may
undergo
degen
chang
progress
loss
cytoplasm
increas
basophilia
shrinkag
nuclei
presenc
measl
viru
giant
cell
may
demonstr
ish
techniqu
figllll
f
giant
cell
also
seen
extra
pulmonari
tissu
fig
g
h
diagnosi
typic
case
measl
usual
made
basi
clinic
sign
symptom
caus
similar
rash
without
featur
measl
includ
rubella
dengu
viru
enterovirus
drug
reaction
especi
ampicillin
typic
case
measl
giantcel
pneumonia
gener
present
littl
diagnost
difficulti
surgic
pathologist
presenc
giant
cell
intranuclear
intracytoplasm
inclus
set
interstiti
pneumon
highli
specif
measl
infect
howev
multinucl
giant
cell
seen
case
measl
pneumonia
absenc
exclud
j
diagnosi
viral
rickettsi
agent
may
also
caus
similar
interstiti
pneumon
without
typic
giant
cell
differenti
previous
note
histopatholog
featur
measl
pneumonia
somewhat
secondari
bacteri
viral
infect
may
modifi
histolog
complic
patholog
diagnosi
fig
viral
pathogen
respiratori
syncyti
recent
discov
hendra
well
granulomat
diseas
lung
may
give
rise
pneumonia
giant
cell
also
consid
differenti
diagnosi
howev
clinic
entiti
distinguish
histori
histopatholog
featur
laboratori
test
ish
test
demonstr
viral
antigen
nucleic
acid
major
case
laboratori
confirm
use
avoid
possibl
confus
rashcaus
ill
diagnost
laboratori
procedur
consist
direct
detect
either
viru
viral
antigen
usual
indirect
immunofluoresc
serolog
method
use
hemagglutin
inhibit
neutral
enzym
immunoassay
specimen
serolog
test
consist
acuteand
convalescentphas
serum
pair
antibodi
appear
within
day
onset
rash
titer
peak
approxim
week
later
altern
presenc
specif
immunoglobulin
igm
antibodi
use
diagnos
recent
infect
human
parainfluenza
virus
hpiv
second
rsv
caus
lower
respiratori
tract
diseas
young
children
human
parainfluenza
virus
negativesens
nonseg
singlestrand
envelop
rna
virus
possess
fusion
hemagglutininneuraminidas
glycoprotein
spike
surfac
fig
ig
four
serotyp
hpiv
belong
famili
paramyxovirida
subfamili
paramyxovirina
genera
respiroviru
hpivl
rubulaviru
virion
variabl
shape
size
rang
human
parainfluenza
virus
spread
respiratori
secret
close
contact
infect
person
contact
contamin
surfac
object
infect
occur
infecti
materi
contact
mucou
membran
eye
mouth
nose
possibl
inhal
droplet
gener
sneez
cough
human
parainfluenza
virus
unstabl
environ
surviv
hour
environment
surfac
readili
inactiv
soap
water
ubiquit
infect
r
zaki
cd
paddock
peopl
childhood
highest
rate
seriou
hpiv
ill
occur
among
young
children
serolog
survey
shown
children
age
year
older
antibodi
antibodi
hpivl
differ
hpiv
serotyp
differ
season
hpivl
caus
biennial
outbreak
croup
fall
caus
annual
biennial
fall
outbreak
human
parainfluenza
peak
activ
occur
spring
earli
summer
month
year
viru
isol
throughout
year
similar
rsv
hpiv
caus
repeat
infect
throughout
life
usual
manifest
upper
respiratori
tract
ill
eg
cold
sore
throat
human
parainfluenza
virus
also
caus
seriou
lower
respiratori
tract
diseas
repeat
infect
eg
pneumonia
bronchiti
bronchiol
especi
among
elderli
among
patient
compromis
immun
system
four
hpiv
differ
clinic
epidemiolog
featur
distinct
clinic
featur
hpivl
croup
ie
laryngotracheobronchit
hpivl
lead
caus
croup
children
wherea
less
frequent
detect
hpivl
caus
upper
lower
respiratori
tract
ill
human
parainfluenza
often
associ
bronchiol
pneumonia
human
parainfluenza
infrequ
detect
possibl
less
like
caus
sever
diseas
incub
period
hpiv
gener
day
hpiv
infect
caus
mild
selflimit
ill
howev
infect
import
caus
bronchiol
croup
pneumonia
may
lifethreaten
infant
newborn
human
parainfluenza
viru
infect
also
increasingli
recogn
import
caus
sever
morbid
mortal
immunocompromis
patient
mortal
bone
marrow
transplant
patient
infect
report
high
patient
sever
hpiv
infect
multinucl
giant
cell
deriv
respiratori
epithelium
may
seen
associ
interstiti
pneumon
organ
chang
fig
b
giant
cell
may
contain
intracytoplasm
eosinophil
inclus
fig
also
report
extrapulmonari
tissu
kidney
bladder
pancrea
viral
caus
giant
cell
pneumonia
includ
meask
rsv
vzv
hsv
consid
histopatholog
differenti
laboratori
test
includ
ihe
use
make
differenti
possibl
fig
diagnosi
infect
hpiv
scan
also
made
viru
isol
direct
detect
viral
antigen
py
enzymelink
immunoassay
eia
immunofluoresc
assay
ifa
clinic
specimen
detect
viral
rna
rtpcr
demonstr
rise
respiratori
syncyti
viru
rsv
common
caus
bronchiol
pneumonia
among
infant
children
year
age
caus
agent
negativesens
nonseg
singlestrand
envelop
rna
viru
virion
variabl
shape
size
rang
nm
respiratori
syncyti
viru
member
famili
paramyxovirida
subfamili
pneumovirina
genu
pneumoviru
ing
poorli
defin
cytoplasm
eosinophil
inclus
parainfluenza
viru
antigen
giant
cell
local
use
immunohistochemistri
ac
h
e
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
distinguish
genet
antigen
two
subgroup
b
subgroup
strain
usual
associ
sever
infect
two
surfac
glycoprotein
g
f
present
envelop
mediat
attach
fusion
respiratori
epithelium
f
protein
also
mediat
coalesc
neighbor
cell
form
characterist
multinucl
syncyti
giant
cell
viru
name
deriv
respiratori
syncyti
viru
spread
respiratori
secret
close
contact
infect
person
contact
contamin
surfac
object
infect
occur
infecti
materi
contact
mucou
membran
eye
mouth
nose
possibl
inhal
droplet
gener
sneez
cough
respiratori
syncyti
viru
unstabl
environ
surviv
hour
environment
surfac
readili
inactiv
soap
water
temper
climat
rsv
infect
usual
occur
annual
commun
outbreak
often
last
sever
month
late
fall
winter
earli
spring
month
time
sever
outbreak
commun
vari
year
year
respiratori
syncyti
viru
spread
effici
among
children
annual
outbreak
children
serolog
evid
rsv
infect
year
age
ill
begin
frequent
fever
runni
nose
cough
sometim
wheez
first
rsv
infect
infant
young
children
sign
symptom
bronchiol
pneumonia
requir
hospit
children
recov
ill
day
major
children
hospit
rsv
infect
month
age
respiratori
syncyti
viru
also
caus
repeat
infect
throughout
life
usual
associ
moderatetosever
coldlik
symptom
howev
sever
lower
respiratori
tract
diseas
may
occur
age
especi
among
elderli
among
compromis
cardiac
pulmonari
immun
system
major
histopatholog
chang
describ
fatal
rsv
infect
includ
necrot
bronchiol
interstiti
pneumonia
fig
b
bronchiallumina
airway
usual
fill
necrot
debri
inflammatori
cell
find
may
accompani
variou
degre
diffus
alveolar
damag
fig
organiz
chang
secondari
bacteri
superinfect
giant
cell
pneumonia
featur
seen
case
fig
multinucl
giant
cell
contain
irregular
intracytoplasm
eosinophil
inclus
surround
clear
halo
inclus
extrem
difficult
identifi
degre
certainti
seen
half
case
fig
viral
caus
giant
cell
pneumonia
consid
histopatholog
differenti
laboratori
test
includ
use
make
differenti
possibl
fig
f
diagnosi
rsv
infect
also
made
viru
isol
direct
detect
viral
antigen
clinic
specimen
eia
ifa
detect
viral
rna
rtpcr
demonstr
rise
rsvspecif
serum
antibodi
combin
approach
see
also
fig
chapter
van
den
hoogen
et
describ
identif
new
viral
agent
clinic
specimen
obtain
patient
respiratori
ill
design
human
metapneumoviru
hmpv
negativesens
nonseg
singlestrand
envelop
rna
viru
virion
variabl
shape
size
rang
fig
categor
famili
paramyxovirida
subfamili
pneumovirina
genu
metapneumoviru
base
genom
sequenc
gene
constel
human
metapneumoviru
distinguish
genet
antigen
two
subgroup
b
similar
rsv
hmpv
infect
ubiquit
occur
infanc
earli
childhood
annual
epidem
peak
occur
winter
spring
month
temper
region
seropreval
studi
reveal
children
age
month
antibodi
hmpv
age
year
patient
evid
past
infect
like
rsv
hmpv
associ
wide
spectrum
respiratori
patient
may
asymptomat
symptom
may
rang
mild
upper
respiratori
tract
ill
sever
bronchiol
pneumonia
although
rsv
hpivl
definit
link
case
lower
respiratori
tract
diseas
infant
young
children
rel
contribut
hmpv
remain
undetermin
like
rsv
hpiv
studi
suggest
hmpv
may
also
contribut
respiratori
diseas
elderli
adult
immunocompromis
histopatholog
descript
featur
hmpv
infect
well
describ
partli
relat
interpret
clinic
signific
viru
detect
context
ubiquit
natur
viru
viru
detect
case
usual
made
cultur
isol
viru
upper
airway
pcr
assay
perform
nasopharyng
aspir
bal
wash
nonhuman
primat
viral
antigen
observ
ciliat
epitheli
cell
type
pneumocyt
alveolar
macrophag
distribut
associ
mild
multifoc
eros
inflammatori
chang
airway
increas
number
foami
macrophag
alveoli
bal
specimen
collect
patient
within
day
posit
hmpv
assay
show
degen
chang
cytoplasm
inclus
within
epitheli
cell
multinucl
giant
cell
histiocyt
intracytoplasm
inclus
illdefin
eosinophil
structur
measur
lung
biopsi
autopsi
tissu
obtain
examin
later
diseas
show
chronic
airway
inflamm
intraalveolar
foami
hemosiderinladen
macrophag
acut
organ
lung
injuri
includ
area
diffus
alveolar
damag
hyalin
membran
format
foci
bronchiol
obliteransorgan
pneumonia
like
reaction
fig
case
typic
multinucl
giant
cell
viral
inclus
identifi
insitu
hybrid
studi
limit
number
human
case
human
metapneumoviru
difficult
identifi
commonli
use
viral
diagnost
procedur
viru
replic
slowli
primari
tertiari
monkey
kidney
cell
line
cytopath
effect
difficult
discern
commerci
monoclon
antibodi
reagent
hmpv
wide
avail
hmpv
studi
conduct
use
rtpcr
assay
demonstr
rise
hmpvspecif
serum
antibodi
two
novel
paramyxovirus
hendra
nipah
recent
identifi
australia
malaysia
virus
associ
acut
febril
enceph
respiratori
tract
diseas
infect
zoonot
hendra
first
identifi
patient
came
close
contact
sick
hors
develop
influenzalik
ill
two
patient
die
pneumon
multiorgan
failur
close
relat
nipah
viru
identifi
outbreak
malaysia
singapor
includ
patient
patient
present
sever
acut
encephalit
syndrom
also
signific
pulmonari
manifest
patient
histori
contact
pig
pig
farmer
bangladesh
outbreak
nipah
enceph
occur
similar
malaysian
outbreak
promin
symptom
fever
headach
vomit
alter
level
conscious
respiratori
ill
much
common
bangladesh
case
howev
cough
dyspnea
reason
increas
involv
respiratori
tract
outbreak
known
epidemiolog
laboratori
investig
identifi
fruit
bat
pteropu
genu
asymptomat
carrier
hendra
nipah
virus
possibl
anim
reservoir
hendra
nipah
virus
belong
recent
design
genu
henipaviru
within
famili
paramyxovirida
subfamili
paramyxovirina
virus
nonseg
negativestrand
rna
virus
compos
helic
nucleocapsid
enclos
within
envelop
form
roughli
spheric
pleomorph
viru
structur
genom
consist
member
subfamili
histopatholog
find
fatal
case
hendra
nipah
infect
similar
vari
degre
cn
respiratori
tract
involv
find
includ
system
vascul
extens
thrombosi
endotheli
cell
damag
necrosi
syncyti
giant
cell
format
affect
vessel
fig
b
f
plaqu
variou
degre
necrosi
associ
inclusionbear
neuron
found
gray
white
matter
cn
fig
multinucl
giant
cell
intranuclear
inclus
occasion
seen
lung
spleen
lymph
node
kidney
fig
g
lung
vascul
fibrinoid
necrosi
seen
major
case
fibrinoid
necrosi
often
involv
sever
adjac
alveoli
frequent
associ
small
vessel
vascul
multinucl
giant
cell
intranuclear
inclus
usual
note
alveolar
space
adjac
necrot
area
histopatholog
chang
bronchiolar
epithelium
uncommon
rare
larg
bronchi
may
show
transmur
inflamm
ulcer
widespread
presenc
nipah
viru
antigen
seen
ihc
endotheli
smooth
muscl
cell
blood
vessel
well
variou
parenchym
cell
fig
diagnosi
nipah
viru
infect
suspect
patient
histori
clinic
manifest
support
characterist
histopatholog
find
diagnost
standpoint
perhap
uniqu
histopatholog
find
presenc
syncyti
parenchym
multinucl
endotheli
cell
featur
occur
approxim
one
fourth
case
use
sensit
criterion
diagnosi
henipah
viru
infect
furthermor
cell
also
seen
measl
viru
rsv
hpiv
herpesvirus
infect
unequivoc
diagnosi
made
laboratori
test
ihc
cell
cultur
isol
pcr
parvovirus
small
nake
virus
possess
singlestrand
dna
genom
requir
activ
divid
cell
complet
viral
replic
cycl
alland
et
identifi
new
parvoviru
genu
bocaviru
associ
lower
respiratori
tract
infect
children
howev
inform
yet
describ
specif
pulmonari
patholog
attribut
newli
identifi
agent
hand
human
parvoviru
member
genu
erythroviru
long
known
caus
human
diseas
well
studi
commonli
recogn
manifest
infect
erythema
infectiosum
approxim
one
third
case
matern
parvoviru
infect
result
intrauterin
parvoviru
infect
place
fetu
increas
risk
sever
anemia
hydrop
death
hydrop
fetali
commonli
recogn
complic
intrauterin
parvoviru
infect
account
case
nonimmun
hydrop
case
tend
cluster
commun
outbreak
erythema
infectiosum
pathophysiolog
effect
histopatholog
find
result
tropism
parvoviru
erythroid
precursor
cell
villi
placenta
patient
nonimmun
hydrop
edemat
fetal
capillari
show
numer
nucleat
erythroid
precursor
contain
parvoviru
inclus
infect
cell
eosinophil
ground
glass
intranuclear
inclus
ringlik
margin
nuclear
chromatin
easili
recogn
context
hydrop
fetu
pathognomon
infect
liver
major
site
blood
product
fetu
princip
organ
affect
intrauterin
infect
inclusionbear
nucleat
erythrocyt
also
frequent
identifi
lung
make
histopatholog
examin
organ
worthwhil
endeavor
confirm
diagnosi
intrauterin
infect
fig
b
howev
cell
may
infrequ
irregularli
distribut
requir
examin
multipl
section
use
ihc
confirm
diagnosi
combin
fever
hemorrhag
caus
differ
virus
rickettsia
bacteria
protozoa
fungi
howev
term
viral
hemorrhag
fever
vhf
usual
reserv
system
infect
character
fever
hemorrhag
caus
special
group
virus
transmit
human
arthropod
rodent
vhf
febril
ill
character
abnorm
vascular
regul
vascular
damag
caus
small
lipidenvelop
rna
virus
syndrom
caus
virus
belong
four
differ
famili
differ
genom
structur
replic
strategi
morpholog
featur
tabl
arenavirus
bunyavirus
filovirus
negativestrand
nucleu
cytoplasm
erythroid
precursor
use
immunohistochemistri
ihe
patient
b
b
h
e
c
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
wherea
fiavivirus
positivestrand
rna
virus
hemorrhag
fever
virus
distribut
worldwid
diseas
caus
tradit
name
accord
locat
first
describ
oldest
best
known
yellow
fever
viru
other
includ
lassa
fever
lymphocyt
choriomening
ebola
dengu
virus
viral
hemorrhag
fever
share
mani
common
patholog
featur
although
overal
chang
vari
among
differ
diseas
similar
patholog
immunopatholog
find
case
vhf
suggest
microvascular
involv
instabl
import
common
pathogen
pathway
lead
shock
bleed
mani
instanc
infect
mononuclear
phagocyt
system
endothelium
thought
play
c
sr
zaki
cd
paddock
ebola
viru
hemorrhag
fever
pulmonari
congest
lack
inflamm
b
numer
filament
ebola
viru
inclus
seen
within
hepatocyt
associ
hepatocellular
necrosi
c
ebola
virusinfect
intra
alveolar
macrophag
seen
colorimetr
insitu
hybrid
use
digoxigeninlabel
probe
viral
antigen
seen
endotheli
cell
interstiti
cell
lung
section
b
h
e
c
digoxigeninlabel
probe
follow
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
figur
yellow
fever
pulmonari
congest
fatal
case
yellow
fever
associ
vaccin
b
yellow
fever
antigen
pulmonari
interstitium
patient
natur
infect
yellow
fever
antigen
usual
seen
outsid
liver
fatal
case
contrast
vaccineassoci
case
viral
antigen
found
varieti
extrapulmonari
critic
role
pathogenesi
vhf
secret
physiolog
activ
substanc
includ
cytokin
inflammatori
mediat
fig
c
autopsi
common
find
includ
widespread
petechi
hemorrhag
ecchymos
involv
skin
mucou
membran
intern
organ
howev
mani
hf
patient
manifest
bleed
may
minim
absent
effus
occasion
hemorrhag
also
frequent
seen
widespread
focal
sometim
massiv
necrosi
commonli
observ
organ
system
often
ischem
natur
necrosi
usual
promin
liver
lymphoid
tissu
organ
includ
heart
lung
spleen
c
extens
midzon
hepat
necrosi
characterist
yellow
fever
abund
antigen
yellow
fever
viru
observ
midzon
area
hepat
lobul
immunohistochem
prepar
c
h
e
b
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
sistent
microscop
featur
found
liver
consist
multifoc
hepatocellular
necrosi
cytoplasm
eosinophilia
councilman
bodi
nuclear
pyknosi
cytolysi
fig
inflammatori
cell
infiltr
necrot
area
usual
mild
present
consist
neutrophil
mononuclear
cell
commonli
observ
histopatholog
chang
lung
includ
variou
degre
hemorrhag
intra
alveolar
edema
interstiti
pneumon
diffus
alveolar
damag
fig
sever
refer
contain
detail
patholog
descript
human
case
recommend
pulmonari
hemorrhag
diffus
alveolar
damag
patient
infect
organ
transplant
note
unlik
case
occur
due
immunosuppress
lcmv
infect
rare
fatal
usual
resolv
specif
treatment
b
abund
lcmv
antigen
area
diagnosi
vhf
suspect
patient
appropri
clinic
manifest
return
endem
area
particularli
travel
rural
area
season
epidem
diseas
activ
diagnosi
suspect
histori
clinic
manifest
also
support
histopatholog
overal
pattern
histopatholog
lesion
may
suggest
specif
diagnosi
howev
similar
patholog
featur
seen
vhf
varieti
viral
rickettsi
bacteri
infect
unequivoc
diagnosi
made
sr
zaki
cd
paddock
lung
show
diffus
alveolar
damag
c
use
immunohistochemistri
abund
lcmv
antigen
seen
within
cytoplasm
hepatocyt
sinusoid
line
cell
associ
area
hepatocellular
necrosi
h
e
b
c
immunoalkalin
phosphatas
stain
naphthol
fastr
hematoxylin
counterstain
laboratori
test
cell
cultur
isol
serolog
pcr
lhc
fig
c
